Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

GREEN LIGHT PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE: ONE LASER FOR DIFFERENT PROSTATE SIZES.

Campobasso D, Marchioni M, Altieri VM, Greco F, De Nunzio C, Destefanis P, Ricciardulli S, Bergamaschi F, Fasolis G, Varvello F, Voce S, Palmieri F, Divan C, Malossini G, Oriti R, Tuccio A, Ruggera L, Tubaro A, Delicato G, Laganà A, Dadone C, Derienzo G, Frattini A, Pucci L, Carrino M, Montefiore F, Germani S, Miano R, Schips L, Rabito S, Ferrari G, Cindolo L.

J Endourol. 2019 Oct 16. doi: 10.1089/end.2019.0478. [Epub ahead of print]

PMID:
31617419
2.

Comprehensive analysis of in-hospital delirium after major surgical oncology procedures.

Bandini M, Marchioni M, Preisser F, Nazzani S, Tian Z, Graefen M, Montorsi F, Saad F, Shariat SF, Schips L, Briganti A, Karakiewicz PI.

Can Urol Assoc J. 2019 Sep 27. doi: 10.5489/cuaj.6030. [Epub ahead of print]

PMID:
31599720
3.

Correlation between Choriocapillaris Density and Retinal Sensitivity in Stargardt Disease.

Mastropasqua R, Senatore A, Di Antonio L, Di Nicola M, Marchioni M, Perna F, Amore F, Borrelli E, De Nicola C, Carpineto P, Toto L.

J Clin Med. 2019 Sep 10;8(9). pii: E1432. doi: 10.3390/jcm8091432.

4.

Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups.

Preisser F, Bandini M, Nazzani S, Mazzone E, Marchioni M, Tian Z, Chun FKH, Saad F, Briganti A, Haese A, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Oncol. 2019 Mar 28. pii: S2588-9311(19)30035-5. doi: 10.1016/j.euo.2019.03.003. [Epub ahead of print]

PMID:
31411975
5.

Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate Cancer.

Preisser F, Nazzani S, Mazzone E, Marchioni M, Bandini M, Tian Z, Haese A, Saad F, Zorn K, Montorsi F, Shariat SF, Graefen M, Tilki D, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Oct;17(5):e939-e945. doi: 10.1016/j.clgc.2019.05.022. Epub 2019 May 27.

PMID:
31375352
6.

A drug safety evaluation of abiraterone acetate in the treatment of prostate cancer.

Castellan P, Castellucci R, Marchioni M, De Nunzio C, Tema G, Primiceri G, Schips L, Cindolo L.

Expert Opin Drug Saf. 2019 Sep;18(9):759-767. doi: 10.1080/14740338.2019.1648428. Review.

PMID:
31353982
7.

Major Acute Cardiovascular Events After Transurethral Prostate Surgery: A Population-based Analysis.

Marchioni M, Cindolo L, Di Nicola M, Schips L, De Sio M, Lima E, Mirone V, Cormio L, Liatsikos E, Porpiglia F, Autorino R; EAU Section of Uro-Technology (ESUT) Research Group.

Urology. 2019 Sep;131:196-203. doi: 10.1016/j.urology.2019.05.014. Epub 2019 May 28.

PMID:
31145946
8.

The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients.

Bandini M, Preisser F, Nazzani S, Marchioni M, Tian Z, Mazzone E, Graefen M, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Eur Urol Oncol. 2018 Aug;1(3):215-222. doi: 10.1016/j.euo.2018.03.007. Epub 2018 May 15.

PMID:
31102624
9.

Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis.

Nazzani S, Preisser F, Bandini M, Marchioni M, Tian Z, Soulières D, Montanari E, Ratti D, Acquati P, Briganti A, Shariat SF, Abdollah F, Carmignani L, Karakiewicz PI.

Eur Urol Oncol. 2018 Sep;1(4):346-351. doi: 10.1016/j.euo.2018.05.008. Epub 2018 May 31.

PMID:
31100257
10.

Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database.

Bandini M, Mazzone E, Preisser F, Nazzani S, Zaffuto E, Marchioni M, Tian Z, Pompe RS, Tilki D, Graefen M, Shariat SF, Montorsi F, Saad F, Briganti A, Karakiewicz P.

Eur Urol Oncol. 2018 Sep;1(4):314-320. doi: 10.1016/j.euo.2018.04.013. Epub 2018 May 15.

PMID:
31100253
11.

Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer.

Preisser F, Marchioni M, Nazzani S, Bandini M, Tian Z, Saad F, Pompe RS, Briganti A, Budäus L, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Oncol. 2018 Jun;1(2):160-168. doi: 10.1016/j.euo.2018.03.006. Epub 2018 May 15.

PMID:
31100241
12.

Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma.

Nazzani S, Preisser F, Mazzone E, Marchioni M, Bandini M, Tian Z, Mistretta FA, Shariat SF, Soulières D, Saad F, Montanari E, Luzzago S, Briganti A, Carmignani L, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Jun;17(3):e602-e611. doi: 10.1016/j.clgc.2019.03.003. Epub 2019 Mar 29.

PMID:
31005472
13.

Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis.

Nazzani S, Bandini M, Preisser F, Mazzone E, Marchioni M, Tian Z, Stubinski R, Clementi MC, Saad F, Shariat SF, Montanari E, Briganti A, Carmignani L, Karakiewicz PI.

Surg Oncol. 2019 Mar;28:201-207. doi: 10.1016/j.suronc.2019.01.011. Epub 2019 Jan 29.

PMID:
30851901
14.

Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group).

Anele UA, Marchioni M, Yang B, Simone G, Uzzo RG, Lau C, Mir MC, Capitanio U, Porter J, Jacobsohn K, de Luyk N, Mari A, Chang K, Fiori C, Sulek J, Mottrie A, White W, Perdona S, Quarto G, Bindayi A, Ashrafi A, Schips L, Berardinelli F, Zhang C, Gallucci M, Ramirez-Backhaus M, Larcher A, Kilday P, Liao M, Langenstroer P, Dasgupta P, Challacombe B, Kutikov A, Minervini A, Rha KH, Sundaram CP, Hampton LJ, Porpiglia F, Aron M, Derweesh I, Autorino R.

World J Urol. 2019 Feb 7. doi: 10.1007/s00345-019-02657-2. [Epub ahead of print]

PMID:
30734072
15.

Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations.

Castellan P, Marchioni M, Castellucci R, De Francesco P, Iantorno R, Schips L, Cindolo L.

Ther Clin Risk Manag. 2018 Dec 6;14:2341-2347. doi: 10.2147/TCRM.S159824. eCollection 2018. Review.

16.

North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients.

Preisser F, Mazzone E, Nazzani S, Marchioni M, Bandini M, Tian Z, Saad F, Soulières D, Shariat SF, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Br J Cancer. 2018 Dec;119(12):1552-1556. doi: 10.1038/s41416-018-0323-3. Epub 2018 Nov 14.

PMID:
30425350
17.

Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy.

Cormio L, Cindolo L, Troiano F, Marchioni M, Di Fino G, Mancini V, Falagario U, Selvaggio O, Sanguedolce F, Fortunato F, Schips L, Carrieri G.

Front Oncol. 2018 Oct 16;8:438. doi: 10.3389/fonc.2018.00438. eCollection 2018.

18.

Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study.

Bandini M, Nazzani S, Marchioni M, Preisser F, Tian Z, Moschini M, Abdollah F, Suardi N, Graefen M, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Feb;17(1):72-78.e4. doi: 10.1016/j.clgc.2018.09.011. Epub 2018 Sep 22.

PMID:
30342845
19.

Impact of Perioperative Blood Transfusions on the Outcomes of Patients Undergoing Kidney Cancer Surgery: A Systematic Review and Pooled Analysis.

Arcaniolo D, Manfredi C, Cindolo L, Marchioni M, Zukovski EP, Mirone V, Anele UA, Guruli G, Grob BM, De Sio M, Autorino R.

Clin Genitourin Cancer. 2019 Feb;17(1):e72-e79. doi: 10.1016/j.clgc.2018.09.010. Epub 2018 Sep 20.

PMID:
30341027
20.

Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma.

Nazzani S, Preisser F, Mazzone E, Marchioni M, Bandini M, Tian Z, Mistretta FA, Shariat SF, Soulières D, Montanari E, Acquati P, Briganti A, Carmignani L, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Feb;17(1):e97-e103. doi: 10.1016/j.clgc.2018.09.017. Epub 2018 Sep 27.

PMID:
30337106
21.

New insight in penile cancer.

Marchioni M, Berardinelli F, De Nunzio C, Spiess P, Porpiglia F, Schips L, Cindolo L.

Minerva Urol Nefrol. 2018 Dec;70(6):559-569. doi: 10.23736/S0393-2249.18.03215-0. Epub 2018 Sep 19. Review.

22.

The Surgical Experience Influences the Safety and Efficacy of Photovaporization of Prostate with 180-W XPS GreenLight Laser: Comparison Between Novices vs Expert Surgeons Learning Curves.

Castellan P, Marchioni M, Rizzoli A, Di Nicola M, Porfilio I, Ghahhari J, Greco F, Schips L, Cindolo L.

J Endourol. 2018 Nov;32(11):1071-1077. doi: 10.1089/end.2018.0437. Epub 2018 Oct 20.

PMID:
30226409
23.

Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of 'real-life' studies.

Marchioni M, Sountoulides P, Bada M, Rapisarda S, De Nunzio C, Tamburro FR, Schips L, Cindolo L.

Ther Adv Urol. 2018 Jul 10;10(10):305-315. doi: 10.1177/1756287218786160. eCollection 2018 Oct.

24.

Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.

Mazzone E, Nazzani S, Preisser F, Tian Z, Marchioni M, Bandini M, Capitanio U, Kapoor A, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, I Karakiewicz P.

Cancer Epidemiol. 2018 Oct;56:118-125. doi: 10.1016/j.canep.2018.08.006. Epub 2018 Aug 30.

PMID:
30173050
25.

Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis.

Preisser F, Nazzani S, Bandini M, Marchioni M, Tian Z, Saad F, Chun FK, Shariat SF, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Int J Urol. 2018 Nov;25(11):929-936. doi: 10.1111/iju.13780. Epub 2018 Aug 26.

PMID:
30146729
26.

Perioperative major acute cardiovascular events after 180-W GreenLight laser photoselective vaporization of the prostate.

Marchioni M, Schips L, Greco F, Frattini A, Neri F, Ruggera L, Fasolis G, Varvello F, Destefanis P, De Rienzo G, Ditonno P, Ferrari G, Cindolo L.

Int Urol Nephrol. 2018 Nov;50(11):1955-1962. doi: 10.1007/s11255-018-1968-9. Epub 2018 Aug 23.

PMID:
30141122
27.

METTL3 regulates WTAP protein homeostasis.

Sorci M, Ianniello Z, Cruciani S, Larivera S, Ginistrelli LC, Capuano E, Marchioni M, Fazi F, Fatica A.

Cell Death Dis. 2018 Jul 23;9(8):796. doi: 10.1038/s41419-018-0843-z.

28.

Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer.

Preisser F, Mazzone E, Nazzani S, Bandini M, Tian Z, Marchioni M, Steuber T, Saad F, Montorsi F, Shariat SF, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol. 2018 Dec;74(6):693-696. doi: 10.1016/j.eururo.2018.07.006. Epub 2018 Jul 20.

PMID:
30037529
29.

Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection.

Preisser F, Nazzani S, Bandini M, Marchioni M, Tian Z, Montorsi F, Saad F, Briganti A, Steuber T, Budäus L, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Urol Oncol. 2018 Aug;36(8):365.e1-365.e7. doi: 10.1016/j.urolonc.2018.05.019. Epub 2018 Jun 7.

PMID:
29887241
30.

Comparison of Perioperative Outcomes Between Open and Robotic Radical Cystectomy: A Population-Based Analysis.

Nazzani S, Mazzone E, Preisser F, Bandini M, Tian Z, Marchioni M, Ratti D, Motta G, Zorn KC, Briganti A, Shariat SF, Montanari E, Carmignani L, Karakiewicz PI.

J Endourol. 2018 Aug;32(8):701-709. doi: 10.1089/end.2018.0313. Epub 2018 Jul 2.

31.

Validation of the Social Security Administration Life Tables (2004-2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results database.

Preisser F, Bandini M, Mazzone E, Nazzani S, Marchioni M, Tian Z, Saad F, Pompe RS, Shariat SF, Heinzer H, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Focus. 2019 Sep;5(5):807-814. doi: 10.1016/j.euf.2018.05.006. Epub 2018 May 22.

PMID:
29802052
32.

Monocenter Experience with 532 Nm-Laser Photoselective-Vaporization of the Prostate by GreenLight XPS™ Laser: Is It Really an Endourological Joker Card?

Ghahhari J, D'Orta C, Rizzoli A, Marchioni M, Primicer GI, De Francesco P, Civitella A, Di Lecce M, Castellan P, Castellucci R, Neri F, Tamburro FR, Cindolo L, Schips L.

Surg Technol Int. 2018 Jun 1;32:164-172.

PMID:
29791696
33.

The Effect of Institution Teaching Status on Perioperative Outcomes After Robotic Partial or Radical Nephrectomy.

Marchioni M, Nazzani S, Preisser F, Bandini M, Tian Z, Kapoor A, Cindolo L, Primiceri G, Carmignani L, Briganti A, Montorsi F, Shariat SF, Schips L, Karakiewicz PI.

J Endourol. 2018 Jul;32(7):621-629. doi: 10.1089/end.2018.0025. Epub 2018 Jun 19.

PMID:
29739253
34.

Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer.

Bandini M, Marchioni M, Preisser F, Zaffuto E, Tian Z, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

World J Urol. 2018 Sep;36(9):1399-1407. doi: 10.1007/s00345-018-2310-y. Epub 2018 May 2.

PMID:
29717358
35.

Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma.

Marchioni M, Harmouch SS, Nazzani S, Bandini M, Preisser F, Tian Z, Kapoor A, Cindolo L, Briganti A, Shariat SF, Schips L, Karakiewicz PI.

Cancer Epidemiol. 2018 Jun;54:112-118. doi: 10.1016/j.canep.2018.04.006. Epub 2018 May 16.

PMID:
29715680
36.

Survival benefit of local versus no local treatment for metastatic prostate cancer-Impact of baseline PSA and metastatic substages.

Pompe RS, Tilki D, Preisser F, Leyh-Bannurah SR, Bandini M, Marchioni M, Gild P, Tian Z, Fossati N, Cindolo L, Shariat SF, Huland H, Graefen M, Briganti A, Karakiewicz PI.

Prostate. 2018 Jul;78(10):753-757. doi: 10.1002/pros.23519. Epub 2018 Apr 16.

PMID:
29663462
37.

A contemporary analysis of radiotherapy effect in surgically treated retroperitoneal sarcoma.

Nazzani S, Bandini M, Marchioni M, Preisser F, Tian Z, Soulières D, Montanari E, Motta G, Acquati P, Briganti A, Shariat SF, Abdollah F, Carmignani L, Karakiewicz PI.

Radiother Oncol. 2018 May;127(2):318-325. doi: 10.1016/j.radonc.2018.03.027. Epub 2018 Apr 6.

PMID:
29631934
38.

The effect of age on cancer-specific mortality in patients with small renal masses: A population-based analysis.

Bandini M, Marchioni M, Pompe RS, Tian Z, Martel T, Chun FK, Cindolo L, Kapoor A, Montorsi F, Shariat SF, Briganti A, Karakiewicz PI.

Can Urol Assoc J. 2018 Jul;12(7):E325-E330. doi: 10.5489/cuaj.4854. Epub 2018 Mar 19.

39.

Local treatment for metastatic prostate cancer: A systematic review.

Tilki D, Pompe RS, Bandini M, Marchioni M, Kretschmer A, Tian Z, Karakiewicz PI, Evans CP.

Int J Urol. 2018 May;25(5):390-403. doi: 10.1111/iju.13535. Epub 2018 Mar 23.

40.

Trifecta and Pentafecta Rates After Robotic Assisted Partial Nephrectomy: Comparative Study of Patients with Renal Masses <4 and ≥4 cm.

Castellucci R, Primiceri G, Castellan P, Marchioni M, D'Orta C, Berardinelli F, Neri F, Cindolo L, Schips L.

J Laparoendosc Adv Surg Tech A. 2018 Jul;28(7):799-803. doi: 10.1089/lap.2017.0657. Epub 2018 Mar 1.

PMID:
29493436
41.

Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram.

Pompe RS, Bandini M, Preisser F, Marchioni M, Zaffuto E, Tian Z, Salomon G, Schlomm T, Huland H, Graefen M, Tilki D, Shariat SF, Karakiewicz PI.

Prostate Cancer Prostatic Dis. 2018 Sep;21(3):386-393. doi: 10.1038/s41391-018-0033-1. Epub 2018 Feb 27.

PMID:
29487397
42.

Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.

Preisser F, Bandini M, Marchioni M, Nazzani S, Tian Z, Pompe RS, Fossati N, Briganti A, Saad F, Shariat SF, Heinzer H, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Prostate. 2018 May;78(6):469-475. doi: 10.1002/pros.23491. Epub 2018 Feb 19.

PMID:
29460290
43.

Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature.

Bandini M, Smith A, Marchioni M, Pompe RS, Martel TF, Cindolo L, Montorsi F, Shariat SF, Briganti A, Kapoor A, Capitanio U, Karakiewicz PI.

Clin Genitourin Cancer. 2018 Jun;16(3):176-183. doi: 10.1016/j.clgc.2018.01.003. Epub 2018 Feb 2. Review.

PMID:
29449091
44.

Therapeutic strategies for organ-confined and non-organ-confined bladder cancer after radical cystectomy.

Marchioni M, Nazzani S, Preisser F, Bandini M, Karakiewicz PI.

Expert Rev Anticancer Ther. 2018 Apr;18(4):377-387. doi: 10.1080/14737140.2018.1439744. Epub 2018 Feb 15. Review.

PMID:
29429376
45.

Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.

Marchioni M, Preisser F, Bandini M, Nazzani S, Tian Z, Kapoor A, Cindolo L, Abdollah F, Tilki D, Briganti A, Montorsi F, Shariat SF, Schips L, Karakiewicz PI.

Eur Urol Focus. 2019 May;5(3):467-473. doi: 10.1016/j.euf.2018.01.007. Epub 2018 Feb 3.

PMID:
29398456
46.

Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients.

Bandini M, Preisser F, Nazzani S, Marchioni M, Tian Z, Fossati N, Gandaglia G, Gallina A, Abdollah F, Shariat SF, Montorsi F, Saad F, Tilki D, Briganti A, Karakiewicz PI.

Eur Urol Focus. 2019 May;5(3):381-388. doi: 10.1016/j.euf.2018.01.009. Epub 2018 Feb 1.

PMID:
29366856
47.

Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study.

Pompe RS, Smith A, Bandini M, Marchioni M, Martel T, Preisser F, Leyh-Bannurah SR, Schiffmann J, Saad F, Huland H, Graefen M, Shariat SF, Tilki D, Karakiewicz PI.

Prostate Cancer Prostatic Dis. 2018 Apr;21(1):71-77. doi: 10.1038/s41391-017-0006-9. Epub 2018 Jan 16.

PMID:
29339806
48.

The Impact of Lymph Node Metastases Burden at Radical Prostatectomy.

Preisser F, Marchioni M, Nazzani S, Bandini M, Tian Z, Pompe RS, Montorsi F, Saad F, Abdollah F, Steuber T, Heinzer H, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Focus. 2019 May;5(3):399-406. doi: 10.1016/j.euf.2017.12.009. Epub 2018 Jan 3.

PMID:
29306731
49.

Primary Vaginal Calculus in a Woman with Disability: Case Report and Literature Review.

Castellan P, Nicolai M, De Francesco P, Di Tizio L, Castellucci R, Bada M, Marchioni M, Cindolo L, Schips L.

J Endourol Case Rep. 2017 Dec 1;3(1):182-185. doi: 10.1089/cren.2017.0100. eCollection 2017.

50.

A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals.

Bandini M, Marchioni M, Preisser F, Nazzani S, Tian Z, Fossati N, Gandaglia G, Shariat SF, Montorsi F, Saad F, Briganti A, Tilki D, Karakiewicz PI.

Eur Urol Focus. 2019 May;5(3):449-456. doi: 10.1016/j.euf.2017.11.013. Epub 2017 Dec 14.

PMID:
29249688

Supplemental Content

Loading ...
Support Center